




Searching News Database: anti-infective
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
HSMN NewsFeed - 26 Sep 2023
Abyrx Receives FDA Clearance for MONTAGE(R) Settable Bone Putty for Use in Cardiothoracic Surgery
Abyrx Receives FDA Clearance for MONTAGE(R) Settable Bone Putty for Use in Cardiothoracic Surgery
HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
HSMN NewsFeed - 8 Jan 2021
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
HSMN NewsFeed - 2 Jan 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
HSMN NewsFeed - 14 Jun 2019
SCYNEXIS Appoints Dr. Nkechi Azie as Vice President of Clinical Development
SCYNEXIS Appoints Dr. Nkechi Azie as Vice President of Clinical Development
HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
HSMN NewsFeed - 24 Aug 2018
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
HSMN NewsFeed - 21 Jun 2018
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
HSMN NewsFeed - 14 Feb 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
HSMN NewsFeed - 18 Apr 2017
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 8 Dec 2016
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
HSMN NewsFeed - 8 Dec 2016
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
HSMN NewsFeed - 26 Sep 2016
Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
HSMN NewsFeed - 22 Jul 2016
ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer
ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer
HSMN NewsFeed - 18 Jul 2016
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
HSMN NewsFeed - 24 May 2016
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
HSMN NewsFeed - 6 Nov 2013
Aurinia Appoints Accomplished Biotech and Pharma Industry Veteran, Stephen W. Zaruby, as President & CEO
Aurinia Appoints Accomplished Biotech and Pharma Industry Veteran, Stephen W. Zaruby, as President & CEO
HSMN NewsFeed - 14 Oct 2013
Teleflex Releases White Paper on Reducing PICC-Related Infection and Thrombosis
Teleflex Releases White Paper on Reducing PICC-Related Infection and Thrombosis
HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
HSMN NewsFeed - 16 Sep 2013
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 22 Jul 2013
Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC(R) Patent Litigation
Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC(R) Patent Litigation
HSMN NewsFeed - 30 Apr 2013
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
HSMN NewsFeed - 13 Feb 2013
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
HSMN NewsFeed - 27 Sep 2012
Amedica Receives FDA 510(k) Clearance For A Second Generation Interbody Fusion Device System
Amedica Receives FDA 510(k) Clearance For A Second Generation Interbody Fusion Device System
HSMN NewsFeed - 14 Sep 2012
Bayer HealthCare To Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries
Bayer HealthCare To Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries
HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
HSMN NewsFeed - 19 Jun 2012
MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft
MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft
HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
HSMN NewsFeed - 19 Jan 2012
Astellas Pharma Europe Ltd. Appoints Mike Crooks to Head up its UK Operations
Astellas Pharma Europe Ltd. Appoints Mike Crooks to Head up its UK Operations
HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
HSMN NewsFeed - 28 Sep 2011
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
HSMN NewsFeed - 20 Jul 2011
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
HSMN NewsFeed - 26 Mar 2011
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
HSMN NewsFeed - 7 Jan 2011
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
HSMN NewsFeed - 1 Dec 2010
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
HSMN NewsFeed - 29 Oct 2010
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
HSMN NewsFeed - 1 Jul 2010
Bacterin International Appoints Three New Members to Its Board of Directors
Bacterin International Appoints Three New Members to Its Board of Directors
HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
HSMN NewsFeed - 6 May 2010
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
HSMN NewsFeed - 2 Dec 2009
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 5 Oct 2009
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
HSMN NewsFeed - 3 Sep 2009
Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
HSMN NewsFeed - 25 Aug 2009
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
HSMN NewsFeed - 27 Mar 2009
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
HSMN NewsFeed - 3 Mar 2009
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
HSMN NewsFeed - 5 Feb 2009
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 5 Dec 2008
FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop
FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop
HSMN NewsFeed - 2 Dec 2008
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
HSMN NewsFeed - 14 Oct 2008
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
HSMN NewsFeed - 18 Sep 2008
Dr. Reddy's Formally Announces its US Specialty Business, Promius Pharma, LLC.
Dr. Reddy's Formally Announces its US Specialty Business, Promius Pharma, LLC.
HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
HSMN NewsFeed - 2 Sep 2008
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
HSMN NewsFeed - 11 Aug 2008
Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
HSMN NewsFeed - 2 Jul 2008
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
HSMN NewsFeed - 23 May 2008
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
HSMN NewsFeed - 7 May 2008
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
HSMN NewsFeed - 21 Apr 2008
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
HSMN NewsFeed - 17 Apr 2008
Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
HSMN NewsFeed - 16 Apr 2008
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
HSMN NewsFeed - 19 Mar 2008
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
HSMN NewsFeed - 27 Feb 2008
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
HSMN NewsFeed - 21 Jan 2008
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
HSMN NewsFeed - 17 Jan 2008
ReachMD Appoints Pharmaceutical Veteran as Executive Vice President of Sales and Business Development
ReachMD Appoints Pharmaceutical Veteran as Executive Vice President of Sales and Business Development
HSMN NewsFeed - 17 Jan 2008
APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
HSMN NewsFeed - 7 Jan 2008
Panacos Appoints Jane Pritchett Henderson Chief Financial and Business Officer
Panacos Appoints Jane Pritchett Henderson Chief Financial and Business Officer
HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
HSMN NewsFeed - 21 Dec 2007
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
HSMN NewsFeed - 26 Nov 2007
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
HSMN NewsFeed - 19 Nov 2007
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
HSMN NewsFeed - 16 Oct 2007
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
HSMN NewsFeed - 4 Oct 2007
Urigen Pharmaceuticals, Inc. Appoints Dennis H. Giesing, PhD as Chief Scientific Officer
Urigen Pharmaceuticals, Inc. Appoints Dennis H. Giesing, PhD as Chief Scientific Officer
HSMN NewsFeed - 27 Sep 2007
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
HSMN NewsFeed - 18 Sep 2007
New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
HSMN NewsFeed - 6 Sep 2007
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
HSMN NewsFeed - 28 Aug 2007
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
HSMN NewsFeed - 24 Aug 2007
Worldwide Skin-Ulcer Treatment Market to See New Growth, Reaching $6.2 Billion by 2011
Worldwide Skin-Ulcer Treatment Market to See New Growth, Reaching $6.2 Billion by 2011
HSMN NewsFeed - 10 Aug 2007
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed - 7 Aug 2007
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
HSMN NewsFeed - 2 Aug 2007
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
HSMN NewsFeed - 11 Jul 2007
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
HSMN NewsFeed - 10 Jul 2007
Angiotech completes enrolment in its Central Venous Catheter (CVC) Pivotal Study
Angiotech completes enrolment in its Central Venous Catheter (CVC) Pivotal Study
HSMN NewsFeed - 28 Jun 2007
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
HSMN NewsFeed - 4 Jun 2007
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 30 Apr 2007
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
HSMN NewsFeed - 24 Apr 2007
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
HSMN NewsFeed - 12 Apr 2007
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
Additional items found! 443

Members Archive contains
443 additional stories matching:
anti-infective
(Password required)
anti-infective
(Password required)